Apotex Fermentation Inc. RX
FDA Approved Drugs

Apotex Fermentation Inc. RX

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX
  • Total Records 278
  • Latest Approval Date Jul 14, 2026
  • Data Source FDA
  • First Approval Date Mar 25, 1987
All
558
View
Unclassified
9
View
Discontinued
263
View
OTC
8
View
RX
278
View
Company Overview

Company

Apotex Fermentation Inc. RX

Country

Canada

Website

Visit Website

Email

services@apoferm.com

Social Profiles

Company Snapshot

Apotex Fermentation Inc. RX

50 Scurfield BoulevardWinnipeg, ManitobaCanada R3Y 1G4

Canada

www.apoferm.com/ services@apoferm.com View on Map
FDA Approved Drug Records ( 278 records )
2018
31 Oct
RX Application: 208453

Drug Name

ABIRATERONE ACETATE

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

2018-10-31

208453 / 1

Active Ingredient

ABIRATERONE ACETATE

Application Number

208453

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

2018-10-31

Regulatory Status

RX

2004
23 Jan
RX Application: 21539

Drug Name

ACETADOTE

Product Number

1

Dosage Form

-

Strength

6GM/30ML (200MG/ML)

Approval Date

2004-01-23

21539 / 1

Active Ingredient

ACETYLCYSTEINE

Application Number

21539

Product Number

1

Dosage Form

-

Strength

6GM/30ML (200MG/ML)

Approval Date

2004-01-23

Regulatory Status

RX

2023
18 Apr
RX Application: 205746

Drug Name

ACETAMINOPHEN

Product Number

1

Dosage Form

-

Strength

1GM/100ML (10MG/ML)

Approval Date

2023-04-18

205746 / 1

Active Ingredient

ACETAMINOPHEN

Application Number

205746

Product Number

1

Dosage Form

-

Strength

1GM/100ML (10MG/ML)

Approval Date

2023-04-18

Regulatory Status

RX

2005
28 Sep
RX Application: 75677

Drug Name

ACYCLOVIR

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2005-09-28

75677 / 1

Active Ingredient

ACYCLOVIR

Application Number

75677

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2005-09-28

Regulatory Status

RX

2005
29 Sep
RX Application: 77309

Drug Name

ACYCLOVIR

Product Number

1

Dosage Form

-

Strength

400MG

Approval Date

2005-09-29

77309 / 1

Active Ingredient

ACYCLOVIR

Application Number

77309

Product Number

1

Dosage Form

-

Strength

400MG

Approval Date

2005-09-29

Regulatory Status

RX

2005
29 Sep
RX Application: 77309

Drug Name

ACYCLOVIR

Product Number

2

Dosage Form

-

Strength

800MG

Approval Date

2005-09-29

77309 / 2

Active Ingredient

ACYCLOVIR

Application Number

77309

Product Number

2

Dosage Form

-

Strength

800MG

Approval Date

2005-09-29

Regulatory Status

RX

2018
06 Jul
RX Application: 205459

Drug Name

ADEFOVIR DIPIVOXIL

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2018-07-06

205459 / 1

Active Ingredient

ADEFOVIR DIPIVOXIL

Application Number

205459

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2018-07-06

Regulatory Status

RX

2026
14 Jul
RX Application: 210725

Drug Name

AFATINIB DIMALEATE

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2026-07-14

210725 / 1

Active Ingredient

AFATINIB DIMALEATE

Application Number

210725

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2026-07-14

Regulatory Status

RX

2026
14 Jul
RX Application: 210725

Drug Name

AFATINIB DIMALEATE

Product Number

2

Dosage Form

-

Strength

EQ 30MG BASE

Approval Date

2026-07-14

210725 / 2

Active Ingredient

AFATINIB DIMALEATE

Application Number

210725

Product Number

2

Dosage Form

-

Strength

EQ 30MG BASE

Approval Date

2026-07-14

Regulatory Status

RX

2026
14 Jul
RX Application: 210725

Drug Name

AFATINIB DIMALEATE

Product Number

3

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2026-07-14

210725 / 3

Active Ingredient

AFATINIB DIMALEATE

Application Number

210725

Product Number

3

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2026-07-14

Regulatory Status

RX

2022
19 May
RX Application: 210701

Drug Name

AMBRISENTAN

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2022-05-19

210701 / 1

Active Ingredient

AMBRISENTAN

Application Number

210701

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2022-05-19

Regulatory Status

RX

2022
19 May
RX Application: 210701

Drug Name

AMBRISENTAN

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2022-05-19

210701 / 2

Active Ingredient

AMBRISENTAN

Application Number

210701

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2022-05-19

Regulatory Status

RX

2019
18 Nov
RX Application: 205199

Drug Name

AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE;EQ 10MG BASE

Approval Date

2019-11-18

205199 / 1

Active Ingredient

AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM

Application Number

205199

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE;EQ 10MG BASE

Approval Date

2019-11-18

Regulatory Status

RX

2019
18 Nov
RX Application: 205199

Drug Name

AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM

Product Number

2

Dosage Form

-

Strength

EQ 5MG BASE;EQ 20MG BASE

Approval Date

2019-11-18

205199 / 2

Active Ingredient

AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM

Application Number

205199

Product Number

2

Dosage Form

-

Strength

EQ 5MG BASE;EQ 20MG BASE

Approval Date

2019-11-18

Regulatory Status

RX

2019
18 Nov
RX Application: 205199

Drug Name

AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM

Product Number

3

Dosage Form

-

Strength

EQ 5MG BASE;EQ 40MG BASE

Approval Date

2019-11-18

205199 / 3

Active Ingredient

AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM

Application Number

205199

Product Number

3

Dosage Form

-

Strength

EQ 5MG BASE;EQ 40MG BASE

Approval Date

2019-11-18

Regulatory Status

RX

2019
18 Nov
RX Application: 205199

Drug Name

AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM

Product Number

4

Dosage Form

-

Strength

EQ 5MG BASE;EQ 80MG BASE

Approval Date

2019-11-18

205199 / 4

Active Ingredient

AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM

Application Number

205199

Product Number

4

Dosage Form

-

Strength

EQ 5MG BASE;EQ 80MG BASE

Approval Date

2019-11-18

Regulatory Status

RX

2019
18 Nov
RX Application: 205199

Drug Name

AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM

Product Number

5

Dosage Form

-

Strength

EQ 10MG BASE;EQ 10MG BASE

Approval Date

2019-11-18

205199 / 5

Active Ingredient

AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM

Application Number

205199

Product Number

5

Dosage Form

-

Strength

EQ 10MG BASE;EQ 10MG BASE

Approval Date

2019-11-18

Regulatory Status

RX

2019
18 Nov
RX Application: 205199

Drug Name

AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM

Product Number

6

Dosage Form

-

Strength

EQ 10MG BASE;EQ 20MG BASE

Approval Date

2019-11-18

205199 / 6

Active Ingredient

AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM

Application Number

205199

Product Number

6

Dosage Form

-

Strength

EQ 10MG BASE;EQ 20MG BASE

Approval Date

2019-11-18

Regulatory Status

RX

2019
18 Nov
RX Application: 205199

Drug Name

AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM

Product Number

7

Dosage Form

-

Strength

EQ 10MG BASE;EQ 40MG BASE

Approval Date

2019-11-18

205199 / 7

Active Ingredient

AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM

Application Number

205199

Product Number

7

Dosage Form

-

Strength

EQ 10MG BASE;EQ 40MG BASE

Approval Date

2019-11-18

Regulatory Status

RX

2019
18 Nov
RX Application: 205199

Drug Name

AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM

Product Number

8

Dosage Form

-

Strength

EQ 10MG BASE;EQ 80MG BASE

Approval Date

2019-11-18

205199 / 8

Active Ingredient

AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM

Application Number

205199

Product Number

8

Dosage Form

-

Strength

EQ 10MG BASE;EQ 80MG BASE

Approval Date

2019-11-18

Regulatory Status

RX

2015
30 Sep
RX Application: 204094

Drug Name

ARIPIPRAZOLE

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

2015-09-30

204094 / 1

Active Ingredient

ARIPIPRAZOLE

Application Number

204094

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

2015-09-30

Regulatory Status

RX

2017
30 May
RX Application: 78983

Drug Name

ATOMOXETINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2017-05-30

78983 / 1

Active Ingredient

ATOMOXETINE HYDROCHLORIDE

Application Number

78983

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2017-05-30

Regulatory Status

RX

2017
30 May
RX Application: 78983

Drug Name

ATOMOXETINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 18MG BASE

Approval Date

2017-05-30

78983 / 2

Active Ingredient

ATOMOXETINE HYDROCHLORIDE

Application Number

78983

Product Number

2

Dosage Form

-

Strength

EQ 18MG BASE

Approval Date

2017-05-30

Regulatory Status

RX

2017
30 May
RX Application: 78983

Drug Name

ATOMOXETINE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

2017-05-30

78983 / 3

Active Ingredient

ATOMOXETINE HYDROCHLORIDE

Application Number

78983

Product Number

3

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

2017-05-30

Regulatory Status

RX

2017
30 May
RX Application: 78983

Drug Name

ATOMOXETINE HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2017-05-30

78983 / 4

Active Ingredient

ATOMOXETINE HYDROCHLORIDE

Application Number

78983

Product Number

4

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2017-05-30

Regulatory Status

RX

2017
30 May
RX Application: 78983

Drug Name

ATOMOXETINE HYDROCHLORIDE

Product Number

5

Dosage Form

-

Strength

EQ 60MG BASE

Approval Date

2017-05-30

78983 / 5

Active Ingredient

ATOMOXETINE HYDROCHLORIDE

Application Number

78983

Product Number

5

Dosage Form

-

Strength

EQ 60MG BASE

Approval Date

2017-05-30

Regulatory Status

RX

2017
30 May
RX Application: 78983

Drug Name

ATOMOXETINE HYDROCHLORIDE

Product Number

6

Dosage Form

-

Strength

EQ 80MG BASE

Approval Date

2017-05-30

78983 / 6

Active Ingredient

ATOMOXETINE HYDROCHLORIDE

Application Number

78983

Product Number

6

Dosage Form

-

Strength

EQ 80MG BASE

Approval Date

2017-05-30

Regulatory Status

RX

2017
30 May
RX Application: 78983

Drug Name

ATOMOXETINE HYDROCHLORIDE

Product Number

7

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2017-05-30

78983 / 7

Active Ingredient

ATOMOXETINE HYDROCHLORIDE

Application Number

78983

Product Number

7

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2017-05-30

Regulatory Status

RX

2021
02 Sep
RX Application: 214969

Drug Name

ATORVASTATIN CALCIUM

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2021-09-02

214969 / 1

Active Ingredient

ATORVASTATIN CALCIUM

Application Number

214969

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2021-09-02

Regulatory Status

RX

2021
02 Sep
RX Application: 214969

Drug Name

ATORVASTATIN CALCIUM

Product Number

2

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2021-09-02

214969 / 2

Active Ingredient

ATORVASTATIN CALCIUM

Application Number

214969

Product Number

2

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2021-09-02

Regulatory Status

RX

2021
02 Sep
RX Application: 214969

Drug Name

ATORVASTATIN CALCIUM

Product Number

3

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2021-09-02

214969 / 3

Active Ingredient

ATORVASTATIN CALCIUM

Application Number

214969

Product Number

3

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2021-09-02

Regulatory Status

RX

2021
02 Sep
RX Application: 214969

Drug Name

ATORVASTATIN CALCIUM

Product Number

4

Dosage Form

-

Strength

EQ 80MG BASE

Approval Date

2021-09-02

214969 / 4

Active Ingredient

ATORVASTATIN CALCIUM

Application Number

214969

Product Number

4

Dosage Form

-

Strength

EQ 80MG BASE

Approval Date

2021-09-02

Regulatory Status

RX

2021
26 Nov
RX Application: 215624

Drug Name

ATROPINE SULFATE

Product Number

1

Dosage Form

-

Strength

1%

Approval Date

2021-11-26

215624 / 1

Active Ingredient

ATROPINE SULFATE

Application Number

215624

Product Number

1

Dosage Form

-

Strength

1%

Approval Date

2021-11-26

Regulatory Status

RX

2009
03 Aug
RX Application: 78621

Drug Name

AZELASTINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

0.05%

Approval Date

2009-08-03

78621 / 1

Active Ingredient

AZELASTINE HYDROCHLORIDE

Application Number

78621

Product Number

1

Dosage Form

-

Strength

0.05%

Approval Date

2009-08-03

Regulatory Status

RX

2017
28 Apr
RX Application: 207712

Drug Name

AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE

Product Number

1

Dosage Form

-

Strength

0.137MG/SPRAY;0.05MG/SPRAY

Approval Date

2017-04-28

207712 / 1

Active Ingredient

AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE

Application Number

207712

Product Number

1

Dosage Form

-

Strength

0.137MG/SPRAY;0.05MG/SPRAY

Approval Date

2017-04-28

Regulatory Status

RX

2007
28 Dec
RX Application: 77883

Drug Name

BALSALAZIDE DISODIUM

Product Number

1

Dosage Form

-

Strength

750MG

Approval Date

2007-12-28

77883 / 1

Active Ingredient

BALSALAZIDE DISODIUM

Application Number

77883

Product Number

1

Dosage Form

-

Strength

750MG

Approval Date

2007-12-28

Regulatory Status

RX

2022
07 Dec
RX Application: 215033

Drug Name

BENDAMUSTINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

100MG/4ML (25MG/ML)

Approval Date

2022-12-07

215033 / 1

Active Ingredient

BENDAMUSTINE HYDROCHLORIDE

Application Number

215033

Product Number

1

Dosage Form

-

Strength

100MG/4ML (25MG/ML)

Approval Date

2022-12-07

Regulatory Status

RX

2015
20 Jul
RX Application: 90449

Drug Name

BIMATOPROST

Product Number

1

Dosage Form

-

Strength

0.03%

Approval Date

2015-07-20

90449 / 1

Active Ingredient

BIMATOPROST

Application Number

90449

Product Number

1

Dosage Form

-

Strength

0.03%

Approval Date

2015-07-20

Regulatory Status

RX

2022
02 May
RX Application: 205533

Drug Name

BORTEZOMIB

Product Number

1

Dosage Form

-

Strength

3.5MG/VIAL

Approval Date

2022-05-02

205533 / 1

Active Ingredient

BORTEZOMIB

Application Number

205533

Product Number

1

Dosage Form

-

Strength

3.5MG/VIAL

Approval Date

2022-05-02

Regulatory Status

RX

2022
31 Jan
RX Application: 78479

Drug Name

BRIMONIDINE TARTRATE

Product Number

1

Dosage Form

-

Strength

0.15%

Approval Date

2022-01-31

78479 / 1

Active Ingredient

BRIMONIDINE TARTRATE

Application Number

78479

Product Number

1

Dosage Form

-

Strength

0.15%

Approval Date

2022-01-31

Regulatory Status

RX

2022
21 Dec
RX Application: 78480

Drug Name

BRIMONIDINE TARTRATE

Product Number

1

Dosage Form

-

Strength

0.1%

Approval Date

2022-12-21

78480 / 1

Active Ingredient

BRIMONIDINE TARTRATE

Application Number

78480

Product Number

1

Dosage Form

-

Strength

0.1%

Approval Date

2022-12-21

Regulatory Status

RX

2022
20 Apr
RX Application: 91442

Drug Name

BRIMONIDINE TARTRATE AND TIMOLOL MALEATE

Product Number

1

Dosage Form

-

Strength

0.2%;EQ 0.5% BASE

Approval Date

2022-04-20

91442 / 1

Active Ingredient

BRIMONIDINE TARTRATE; TIMOLOL MALEATE

Application Number

91442

Product Number

1

Dosage Form

-

Strength

0.2%;EQ 0.5% BASE

Approval Date

2022-04-20

Regulatory Status

RX

2026
23 Feb
RX Application: 214875

Drug Name

BRIVARACETAM

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2026-02-23

214875 / 1

Active Ingredient

BRIVARACETAM

Application Number

214875

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2026-02-23

Regulatory Status

RX

2026
23 Feb
RX Application: 214875

Drug Name

BRIVARACETAM

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

2026-02-23

214875 / 2

Active Ingredient

BRIVARACETAM

Application Number

214875

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

2026-02-23

Regulatory Status

RX

2026
23 Feb
RX Application: 214875

Drug Name

BRIVARACETAM

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

2026-02-23

214875 / 3

Active Ingredient

BRIVARACETAM

Application Number

214875

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

2026-02-23

Regulatory Status

RX

2026
23 Feb
RX Application: 214875

Drug Name

BRIVARACETAM

Product Number

4

Dosage Form

-

Strength

75MG

Approval Date

2026-02-23

214875 / 4

Active Ingredient

BRIVARACETAM

Application Number

214875

Product Number

4

Dosage Form

-

Strength

75MG

Approval Date

2026-02-23

Regulatory Status

RX

2026
23 Feb
RX Application: 214875

Drug Name

BRIVARACETAM

Product Number

5

Dosage Form

-

Strength

100MG

Approval Date

2026-02-23

214875 / 5

Active Ingredient

BRIVARACETAM

Application Number

214875

Product Number

5

Dosage Form

-

Strength

100MG

Approval Date

2026-02-23

Regulatory Status

RX

2024
08 Jul
RX Application: 207334

Drug Name

BROMFENAC SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 0.07% ACID

Approval Date

2024-07-08

207334 / 1

Active Ingredient

BROMFENAC SODIUM

Application Number

207334

Product Number

1

Dosage Form

-

Strength

EQ 0.07% ACID

Approval Date

2024-07-08

Regulatory Status

RX

2006
17 Jan
RX Application: 76143

Drug Name

BUPROPION HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

75MG

Approval Date

2006-01-17

76143 / 1

Active Ingredient

BUPROPION HYDROCHLORIDE

Application Number

76143

Product Number

1

Dosage Form

-

Strength

75MG

Approval Date

2006-01-17

Regulatory Status

RX

2006
17 Jan
RX Application: 76143

Drug Name

BUPROPION HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

2006-01-17

76143 / 2

Active Ingredient

BUPROPION HYDROCHLORIDE

Application Number

76143

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

2006-01-17

Regulatory Status

RX

2002
04 Dec
RX Application: 75499

Drug Name

BUTORPHANOL TARTRATE

Product Number

1

Dosage Form

-

Strength

1MG/SPRAY

Approval Date

2002-12-04

75499 / 1

Active Ingredient

BUTORPHANOL TARTRATE

Application Number

75499

Product Number

1

Dosage Form

-

Strength

1MG/SPRAY

Approval Date

2002-12-04

Regulatory Status

RX

2009
11 Jun
RX Application: 22348

Drug Name

CALDOLOR

Product Number

2

Dosage Form

-

Strength

800MG/8ML (100MG/ML)

Approval Date

2009-06-11

22348 / 2

Active Ingredient

IBUPROFEN

Application Number

22348

Product Number

2

Dosage Form

-

Strength

800MG/8ML (100MG/ML)

Approval Date

2009-06-11

Regulatory Status

RX

2019
25 Jan
RX Application: 22348

Drug Name

CALDOLOR

Product Number

3

Dosage Form

-

Strength

800MG/200ML (4MG/ML)

Approval Date

2019-01-25

22348 / 3

Active Ingredient

IBUPROFEN

Application Number

22348

Product Number

3

Dosage Form

-

Strength

800MG/200ML (4MG/ML)

Approval Date

2019-01-25

Regulatory Status

RX

2026
14 Apr
RX Application: 210449

Drug Name

CANAGLIFLOZIN

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2026-04-14

210449 / 1

Active Ingredient

CANAGLIFLOZIN

Application Number

210449

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2026-04-14

Regulatory Status

RX

2026
14 Apr
RX Application: 210449

Drug Name

CANAGLIFLOZIN

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2026-04-14

210449 / 2

Active Ingredient

CANAGLIFLOZIN

Application Number

210449

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2026-04-14

Regulatory Status

RX

2002
27 Feb
RX Application: 75948

Drug Name

CARBAMAZEPINE

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2002-02-27

75948 / 1

Active Ingredient

CARBAMAZEPINE

Application Number

75948

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2002-02-27

Regulatory Status

RX

2021
21 Sep
RX Application: 208075

Drug Name

CEFTAROLINE FOSAMIL

Product Number

1

Dosage Form

-

Strength

400MG/VIAL

Approval Date

2021-09-21

208075 / 1

Active Ingredient

CEFTAROLINE FOSAMIL

Application Number

208075

Product Number

1

Dosage Form

-

Strength

400MG/VIAL

Approval Date

2021-09-21

Regulatory Status

RX

2021
21 Sep
RX Application: 208075

Drug Name

CEFTAROLINE FOSAMIL

Product Number

2

Dosage Form

-

Strength

600MG/VIAL

Approval Date

2021-09-21

208075 / 2

Active Ingredient

CEFTAROLINE FOSAMIL

Application Number

208075

Product Number

2

Dosage Form

-

Strength

600MG/VIAL

Approval Date

2021-09-21

Regulatory Status

RX

2006
12 May
RX Application: 65180

Drug Name

CEFTRIAXONE

Product Number

1

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2006-05-12

65180 / 1

Active Ingredient

CEFTRIAXONE SODIUM

Application Number

65180

Product Number

1

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2006-05-12

Regulatory Status

RX

2015
02 Jun
RX Application: 204197

Drug Name

CELECOXIB

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

2015-06-02

204197 / 1

Active Ingredient

CELECOXIB

Application Number

204197

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

2015-06-02

Regulatory Status

RX

2015
02 Jun
RX Application: 204197

Drug Name

CELECOXIB

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

2015-06-02

204197 / 2

Active Ingredient

CELECOXIB

Application Number

204197

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

2015-06-02

Regulatory Status

RX

2015
02 Jun
RX Application: 204197

Drug Name

CELECOXIB

Product Number

3

Dosage Form

-

Strength

200MG

Approval Date

2015-06-02

204197 / 3

Active Ingredient

CELECOXIB

Application Number

204197

Product Number

3

Dosage Form

-

Strength

200MG

Approval Date

2015-06-02

Regulatory Status

RX

2004
10 Dec
RX Application: 77030

Drug Name

CILOSTAZOL

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

2004-12-10

77030 / 1

Active Ingredient

CILOSTAZOL

Application Number

77030

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

2004-12-10

Regulatory Status

RX

2004
10 Dec
RX Application: 77030

Drug Name

CILOSTAZOL

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

2004-12-10

77030 / 2

Active Ingredient

CILOSTAZOL

Application Number

77030

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

2004-12-10

Regulatory Status

RX

2025
24 Nov
RX Application: 218425

Drug Name

CLADRIBINE

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2025-11-24

218425 / 1

Active Ingredient

CLADRIBINE

Application Number

218425

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2025-11-24

Regulatory Status

RX

2002
09 May
RX Application: 65040

Drug Name

CYCLOSPORINE

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2002-05-09

65040 / 1

Active Ingredient

CYCLOSPORINE

Application Number

65040

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2002-05-09

Regulatory Status

RX

2002
09 May
RX Application: 65040

Drug Name

CYCLOSPORINE

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

2002-05-09

65040 / 2

Active Ingredient

CYCLOSPORINE

Application Number

65040

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

2002-05-09

Regulatory Status

RX

2019
10 Jul
RX Application: 210721

Drug Name

CYCLOSPORINE

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2019-07-10

210721 / 1

Active Ingredient

CYCLOSPORINE

Application Number

210721

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2019-07-10

Regulatory Status

RX

2019
10 Jul
RX Application: 210721

Drug Name

CYCLOSPORINE

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2019-07-10

210721 / 2

Active Ingredient

CYCLOSPORINE

Application Number

210721

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2019-07-10

Regulatory Status

RX

2019
10 Jul
RX Application: 210721

Drug Name

CYCLOSPORINE

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

2019-07-10

210721 / 3

Active Ingredient

CYCLOSPORINE

Application Number

210721

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

2019-07-10

Regulatory Status

RX

2023
15 Dec
RX Application: 208070

Drug Name

DABIGATRAN ETEXILATE MESYLATE

Product Number

1

Dosage Form

-

Strength

EQ 75MG BASE

Approval Date

2023-12-15

208070 / 1

Active Ingredient

DABIGATRAN ETEXILATE MESYLATE

Application Number

208070

Product Number

1

Dosage Form

-

Strength

EQ 75MG BASE

Approval Date

2023-12-15

Regulatory Status

RX

2023
15 Dec
RX Application: 208070

Drug Name

DABIGATRAN ETEXILATE MESYLATE

Product Number

2

Dosage Form

-

Strength

EQ 110MG BASE

Approval Date

2023-12-15

208070 / 2

Active Ingredient

DABIGATRAN ETEXILATE MESYLATE

Application Number

208070

Product Number

2

Dosage Form

-

Strength

EQ 110MG BASE

Approval Date

2023-12-15

Regulatory Status

RX

2023
15 Dec
RX Application: 208070

Drug Name

DABIGATRAN ETEXILATE MESYLATE

Product Number

3

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2023-12-15

208070 / 3

Active Ingredient

DABIGATRAN ETEXILATE MESYLATE

Application Number

208070

Product Number

3

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2023-12-15

Regulatory Status

RX

2016
10 Jun
RX Application: 202103

Drug Name

DASATINIB

Product Number

1

Dosage Form

-

Strength

20MG

Approval Date

2016-06-10

202103 / 1

Active Ingredient

DASATINIB

Application Number

202103

Product Number

1

Dosage Form

-

Strength

20MG

Approval Date

2016-06-10

Regulatory Status

RX

2016
10 Jun
RX Application: 202103

Drug Name

DASATINIB

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2016-06-10

202103 / 2

Active Ingredient

DASATINIB

Application Number

202103

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2016-06-10

Regulatory Status

RX

2016
10 Jun
RX Application: 202103

Drug Name

DASATINIB

Product Number

3

Dosage Form

-

Strength

70MG

Approval Date

2016-06-10

202103 / 3

Active Ingredient

DASATINIB

Application Number

202103

Product Number

3

Dosage Form

-

Strength

70MG

Approval Date

2016-06-10

Regulatory Status

RX

2016
10 Jun
RX Application: 202103

Drug Name

DASATINIB

Product Number

4

Dosage Form

-

Strength

100MG

Approval Date

2016-06-10

202103 / 4

Active Ingredient

DASATINIB

Application Number

202103

Product Number

4

Dosage Form

-

Strength

100MG

Approval Date

2016-06-10

Regulatory Status

RX

2021
23 Nov
RX Application: 203180

Drug Name

DASATINIB

Product Number

1

Dosage Form

-

Strength

80MG

Approval Date

2021-11-23

203180 / 1

Active Ingredient

DASATINIB

Application Number

203180

Product Number

1

Dosage Form

-

Strength

80MG

Approval Date

2021-11-23

Regulatory Status

RX

2021
23 Nov
RX Application: 203180

Drug Name

DASATINIB

Product Number

2

Dosage Form

-

Strength

140MG

Approval Date

2021-11-23

203180 / 2

Active Ingredient

DASATINIB

Application Number

203180

Product Number

2

Dosage Form

-

Strength

140MG

Approval Date

2021-11-23

Regulatory Status

RX

2006
07 Mar
RX Application: 77414

Drug Name

DESMOPRESSIN ACETATE

Product Number

1

Dosage Form

-

Strength

0.1MG

Approval Date

2006-03-07

77414 / 1

Active Ingredient

DESMOPRESSIN ACETATE

Application Number

77414

Product Number

1

Dosage Form

-

Strength

0.1MG

Approval Date

2006-03-07

Regulatory Status

RX

2006
07 Mar
RX Application: 77414

Drug Name

DESMOPRESSIN ACETATE

Product Number

2

Dosage Form

-

Strength

0.2MG

Approval Date

2006-03-07

77414 / 2

Active Ingredient

DESMOPRESSIN ACETATE

Application Number

77414

Product Number

2

Dosage Form

-

Strength

0.2MG

Approval Date

2006-03-07

Regulatory Status

RX

2005
27 Jan
RX Application: 76703

Drug Name

DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION)

Product Number

1

Dosage Form

-

Strength

0.01MG/SPRAY

Approval Date

2005-01-27

76703 / 1

Active Ingredient

DESMOPRESSIN ACETATE

Application Number

76703

Product Number

1

Dosage Form

-

Strength

0.01MG/SPRAY

Approval Date

2005-01-27

Regulatory Status

RX

2023
23 Aug
RX Application: 217695

Drug Name

DEXAMETHASONE

Product Number

1

Dosage Form

-

Strength

0.5MG

Approval Date

2023-08-23

217695 / 1

Active Ingredient

DEXAMETHASONE

Application Number

217695

Product Number

1

Dosage Form

-

Strength

0.5MG

Approval Date

2023-08-23

Regulatory Status

RX

2023
23 Aug
RX Application: 217695

Drug Name

DEXAMETHASONE

Product Number

2

Dosage Form

-

Strength

0.75MG

Approval Date

2023-08-23

217695 / 2

Active Ingredient

DEXAMETHASONE

Application Number

217695

Product Number

2

Dosage Form

-

Strength

0.75MG

Approval Date

2023-08-23

Regulatory Status

RX

2023
23 Aug
RX Application: 217695

Drug Name

DEXAMETHASONE

Product Number

3

Dosage Form

-

Strength

1MG

Approval Date

2023-08-23

217695 / 3

Active Ingredient

DEXAMETHASONE

Application Number

217695

Product Number

3

Dosage Form

-

Strength

1MG

Approval Date

2023-08-23

Regulatory Status

RX

2023
23 Aug
RX Application: 217695

Drug Name

DEXAMETHASONE

Product Number

4

Dosage Form

-

Strength

1.5MG

Approval Date

2023-08-23

217695 / 4

Active Ingredient

DEXAMETHASONE

Application Number

217695

Product Number

4

Dosage Form

-

Strength

1.5MG

Approval Date

2023-08-23

Regulatory Status

RX

2023
23 Aug
RX Application: 217695

Drug Name

DEXAMETHASONE

Product Number

5

Dosage Form

-

Strength

2MG

Approval Date

2023-08-23

217695 / 5

Active Ingredient

DEXAMETHASONE

Application Number

217695

Product Number

5

Dosage Form

-

Strength

2MG

Approval Date

2023-08-23

Regulatory Status

RX

2023
23 Aug
RX Application: 217695

Drug Name

DEXAMETHASONE

Product Number

6

Dosage Form

-

Strength

4MG

Approval Date

2023-08-23

217695 / 6

Active Ingredient

DEXAMETHASONE

Application Number

217695

Product Number

6

Dosage Form

-

Strength

4MG

Approval Date

2023-08-23

Regulatory Status

RX

2023
23 Aug
RX Application: 217695

Drug Name

DEXAMETHASONE

Product Number

7

Dosage Form

-

Strength

6MG

Approval Date

2023-08-23

217695 / 7

Active Ingredient

DEXAMETHASONE

Application Number

217695

Product Number

7

Dosage Form

-

Strength

6MG

Approval Date

2023-08-23

Regulatory Status

RX

2022
06 May
RX Application: 207714

Drug Name

DICLOFENAC SODIUM

Product Number

1

Dosage Form

-

Strength

2%

Approval Date

2022-05-06

207714 / 1

Active Ingredient

DICLOFENAC SODIUM

Application Number

207714

Product Number

1

Dosage Form

-

Strength

2%

Approval Date

2022-05-06

Regulatory Status

RX

1998
06 Aug
RX Application: 74943

Drug Name

DILTIAZEM HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

240MG

Approval Date

1998-08-06

74943 / 1

Active Ingredient

DILTIAZEM HYDROCHLORIDE

Application Number

74943

Product Number

1

Dosage Form

-

Strength

240MG

Approval Date

1998-08-06

Regulatory Status

RX

2000
19 Dec
RX Application: 74943

Drug Name

DILTIAZEM HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

180MG

Approval Date

2000-12-19

74943 / 2

Active Ingredient

DILTIAZEM HYDROCHLORIDE

Application Number

74943

Product Number

2

Dosage Form

-

Strength

180MG

Approval Date

2000-12-19

Regulatory Status

RX

2000
19 Dec
RX Application: 74943

Drug Name

DILTIAZEM HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

120MG

Approval Date

2000-12-19

74943 / 3

Active Ingredient

DILTIAZEM HYDROCHLORIDE

Application Number

74943

Product Number

3

Dosage Form

-

Strength

120MG

Approval Date

2000-12-19

Regulatory Status

RX

2000
18 Oct
RX Application: 75580

Drug Name

DOXAZOSIN MESYLATE

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2000-10-18

75580 / 1

Active Ingredient

DOXAZOSIN MESYLATE

Application Number

75580

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2000-10-18

Regulatory Status

RX

2000
18 Oct
RX Application: 75580

Drug Name

DOXAZOSIN MESYLATE

Product Number

2

Dosage Form

-

Strength

EQ 2MG BASE

Approval Date

2000-10-18

75580 / 2

Active Ingredient

DOXAZOSIN MESYLATE

Application Number

75580

Product Number

2

Dosage Form

-

Strength

EQ 2MG BASE

Approval Date

2000-10-18

Regulatory Status

RX

2000
18 Oct
RX Application: 75580

Drug Name

DOXAZOSIN MESYLATE

Product Number

3

Dosage Form

-

Strength

EQ 4MG BASE

Approval Date

2000-10-18

75580 / 3

Active Ingredient

DOXAZOSIN MESYLATE

Application Number

75580

Product Number

3

Dosage Form

-

Strength

EQ 4MG BASE

Approval Date

2000-10-18

Regulatory Status

RX

2000
18 Oct
RX Application: 75580

Drug Name

DOXAZOSIN MESYLATE

Product Number

4

Dosage Form

-

Strength

EQ 8MG BASE

Approval Date

2000-10-18

75580 / 4

Active Ingredient

DOXAZOSIN MESYLATE

Application Number

75580

Product Number

4

Dosage Form

-

Strength

EQ 8MG BASE

Approval Date

2000-10-18

Regulatory Status

RX

2024
11 Jul
RX Application: 217170

Drug Name

DOXYCYCLINE

Product Number

1

Dosage Form

-

Strength

40MG

Approval Date

2024-07-11

217170 / 1

Active Ingredient

DOXYCYCLINE

Application Number

217170

Product Number

1

Dosage Form

-

Strength

40MG

Approval Date

2024-07-11

Regulatory Status

RX

2023
07 Dec
RX Application: 211236

Drug Name

ESLICARBAZEPINE ACETATE

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2023-12-07

211236 / 1

Active Ingredient

ESLICARBAZEPINE ACETATE

Application Number

211236

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2023-12-07

Regulatory Status

RX

2023
07 Dec
RX Application: 211236

Drug Name

ESLICARBAZEPINE ACETATE

Product Number

2

Dosage Form

-

Strength

400MG

Approval Date

2023-12-07

211236 / 2

Active Ingredient

ESLICARBAZEPINE ACETATE

Application Number

211236

Product Number

2

Dosage Form

-

Strength

400MG

Approval Date

2023-12-07

Regulatory Status

RX

2023
07 Dec
RX Application: 211236

Drug Name

ESLICARBAZEPINE ACETATE

Product Number

3

Dosage Form

-

Strength

600MG

Approval Date

2023-12-07

211236 / 3

Active Ingredient

ESLICARBAZEPINE ACETATE

Application Number

211236

Product Number

3

Dosage Form

-

Strength

600MG

Approval Date

2023-12-07

Regulatory Status

RX

2023
07 Dec
RX Application: 211236

Drug Name

ESLICARBAZEPINE ACETATE

Product Number

4

Dosage Form

-

Strength

800MG

Approval Date

2023-12-07

211236 / 4

Active Ingredient

ESLICARBAZEPINE ACETATE

Application Number

211236

Product Number

4

Dosage Form

-

Strength

800MG

Approval Date

2023-12-07

Regulatory Status

RX

2000
28 Jul
RX Application: 75419

Drug Name

ETODOLAC

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2000-07-28

75419 / 1

Active Ingredient

ETODOLAC

Application Number

75419

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2000-07-28

Regulatory Status

RX

2000
28 Jul
RX Application: 75419

Drug Name

ETODOLAC

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2000-07-28

75419 / 2

Active Ingredient

ETODOLAC

Application Number

75419

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2000-07-28

Regulatory Status

RX

2002
03 Dec
RX Application: 76004

Drug Name

ETODOLAC

Product Number

1

Dosage Form

-

Strength

400MG

Approval Date

2002-12-03

76004 / 1

Active Ingredient

ETODOLAC

Application Number

76004

Product Number

1

Dosage Form

-

Strength

400MG

Approval Date

2002-12-03

Regulatory Status

RX

2002
03 Dec
RX Application: 76004

Drug Name

ETODOLAC

Product Number

2

Dosage Form

-

Strength

500MG

Approval Date

2002-12-03

76004 / 2

Active Ingredient

ETODOLAC

Application Number

76004

Product Number

2

Dosage Form

-

Strength

500MG

Approval Date

2002-12-03

Regulatory Status

RX

2026
01 May
RX Application: 220837

Drug Name

EVDI

Product Number

1

Dosage Form

-

Strength

1MG/20ML (0.05MG/ML)

Approval Date

2026-05-01

220837 / 1

Active Ingredient

TRABECTEDIN

Application Number

220837

Product Number

1

Dosage Form

-

Strength

1MG/20ML (0.05MG/ML)

Approval Date

2026-05-01

Regulatory Status

RX

2026
12 May
RX Application: 218488

Drug Name

EVEROLIMUS

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2026-05-12

218488 / 1

Active Ingredient

EVEROLIMUS

Application Number

218488

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2026-05-12

Regulatory Status

RX

2026
12 May
RX Application: 218488

Drug Name

EVEROLIMUS

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2026-05-12

218488 / 2

Active Ingredient

EVEROLIMUS

Application Number

218488

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2026-05-12

Regulatory Status

RX

2026
12 May
RX Application: 218488

Drug Name

EVEROLIMUS

Product Number

3

Dosage Form

-

Strength

7.5MG

Approval Date

2026-05-12

218488 / 3

Active Ingredient

EVEROLIMUS

Application Number

218488

Product Number

3

Dosage Form

-

Strength

7.5MG

Approval Date

2026-05-12

Regulatory Status

RX

2026
12 May
RX Application: 218488

Drug Name

EVEROLIMUS

Product Number

4

Dosage Form

-

Strength

10MG

Approval Date

2026-05-12

218488 / 4

Active Ingredient

EVEROLIMUS

Application Number

218488

Product Number

4

Dosage Form

-

Strength

10MG

Approval Date

2026-05-12

Regulatory Status

RX

2013
26 Jul
RX Application: 202252

Drug Name

FENOFIBRATE (MICRONIZED)

Product Number

1

Dosage Form

-

Strength

43MG

Approval Date

2013-07-26

202252 / 1

Active Ingredient

FENOFIBRATE

Application Number

202252

Product Number

1

Dosage Form

-

Strength

43MG

Approval Date

2013-07-26

Regulatory Status

RX

2013
26 Jul
RX Application: 202252

Drug Name

FENOFIBRATE (MICRONIZED)

Product Number

2

Dosage Form

-

Strength

130MG

Approval Date

2013-07-26

202252 / 2

Active Ingredient

FENOFIBRATE

Application Number

202252

Product Number

2

Dosage Form

-

Strength

130MG

Approval Date

2013-07-26

Regulatory Status

RX

2026
02 Feb
RX Application: 219559

Drug Name

FIDAXOMICIN

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2026-02-02

219559 / 1

Active Ingredient

FIDAXOMICIN

Application Number

219559

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2026-02-02

Regulatory Status

RX

2020
18 Dec
RX Application: 207993

Drug Name

FINGOLIMOD HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 0.5MG BASE

Approval Date

2020-12-18

207993 / 1

Active Ingredient

FINGOLIMOD HYDROCHLORIDE

Application Number

207993

Product Number

1

Dosage Form

-

Strength

EQ 0.5MG BASE

Approval Date

2020-12-18

Regulatory Status

RX

2007
12 Sep
RX Application: 77538

Drug Name

FLUTICASONE PROPIONATE

Product Number

1

Dosage Form

-

Strength

0.05MG/SPRAY

Approval Date

2007-09-12

77538 / 1

Active Ingredient

FLUTICASONE PROPIONATE

Application Number

77538

Product Number

1

Dosage Form

-

Strength

0.05MG/SPRAY

Approval Date

2007-09-12

Regulatory Status

RX

2001
07 May
RX Application: 75902

Drug Name

FLUVOXAMINE MALEATE

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2001-05-07

75902 / 1

Active Ingredient

FLUVOXAMINE MALEATE

Application Number

75902

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2001-05-07

Regulatory Status

RX

2001
07 May
RX Application: 75902

Drug Name

FLUVOXAMINE MALEATE

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2001-05-07

75902 / 2

Active Ingredient

FLUVOXAMINE MALEATE

Application Number

75902

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2001-05-07

Regulatory Status

RX

2001
07 May
RX Application: 75902

Drug Name

FLUVOXAMINE MALEATE

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

2001-05-07

75902 / 3

Active Ingredient

FLUVOXAMINE MALEATE

Application Number

75902

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

2001-05-07

Regulatory Status

RX

2007
22 Mar
RX Application: 77941

Drug Name

FUROSEMIDE

Product Number

1

Dosage Form

-

Strength

10MG/ML

Approval Date

2007-03-22

77941 / 1

Active Ingredient

FUROSEMIDE

Application Number

77941

Product Number

1

Dosage Form

-

Strength

10MG/ML

Approval Date

2007-03-22

Regulatory Status

RX

2001
13 Jun
RX Application: 75795

Drug Name

GLIPIZIDE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2001-06-13

75795 / 1

Active Ingredient

GLIPIZIDE

Application Number

75795

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2001-06-13

Regulatory Status

RX

2001
13 Jun
RX Application: 75795

Drug Name

GLIPIZIDE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2001-06-13

75795 / 2

Active Ingredient

GLIPIZIDE

Application Number

75795

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2001-06-13

Regulatory Status

RX

2018
25 Jul
RX Application: 205430

Drug Name

GUANFACINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2018-07-25

205430 / 1

Active Ingredient

GUANFACINE HYDROCHLORIDE

Application Number

205430

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2018-07-25

Regulatory Status

RX

2018
25 Jul
RX Application: 205430

Drug Name

GUANFACINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 2MG BASE

Approval Date

2018-07-25

205430 / 2

Active Ingredient

GUANFACINE HYDROCHLORIDE

Application Number

205430

Product Number

2

Dosage Form

-

Strength

EQ 2MG BASE

Approval Date

2018-07-25

Regulatory Status

RX

2018
25 Jul
RX Application: 205430

Drug Name

GUANFACINE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

EQ 3MG BASE

Approval Date

2018-07-25

205430 / 3

Active Ingredient

GUANFACINE HYDROCHLORIDE

Application Number

205430

Product Number

3

Dosage Form

-

Strength

EQ 3MG BASE

Approval Date

2018-07-25

Regulatory Status

RX

2018
25 Jul
RX Application: 205430

Drug Name

GUANFACINE HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

EQ 4MG BASE

Approval Date

2018-07-25

205430 / 4

Active Ingredient

GUANFACINE HYDROCHLORIDE

Application Number

205430

Product Number

4

Dosage Form

-

Strength

EQ 4MG BASE

Approval Date

2018-07-25

Regulatory Status

RX

2026
05 Feb
RX Application: 219856

Drug Name

HYDROCORTISONE SODIUM SUCCINATE

Product Number

1

Dosage Form

-

Strength

EQ 100MG BASE/VIAL

Approval Date

2026-02-05

219856 / 1

Active Ingredient

HYDROCORTISONE SODIUM SUCCINATE

Application Number

219856

Product Number

1

Dosage Form

-

Strength

EQ 100MG BASE/VIAL

Approval Date

2026-02-05

Regulatory Status

RX

2015
16 Oct
RX Application: 204222

Drug Name

IBANDRONATE SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 3MG BASE/3ML

Approval Date

2015-10-16

204222 / 1

Active Ingredient

IBANDRONATE SODIUM

Application Number

204222

Product Number

1

Dosage Form

-

Strength

EQ 3MG BASE/3ML

Approval Date

2015-10-16

Regulatory Status

RX

2021
30 Jun
RX Application: 209437

Drug Name

ICOSAPENT ETHYL

Product Number

1

Dosage Form

-

Strength

1GM

Approval Date

2021-06-30

209437 / 1

Active Ingredient

ICOSAPENT ETHYL

Application Number

209437

Product Number

1

Dosage Form

-

Strength

1GM

Approval Date

2021-06-30

Regulatory Status

RX

2016
05 Aug
RX Application: 79179

Drug Name

IMATINIB MESYLATE

Product Number

1

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2016-08-05

79179 / 1

Active Ingredient

IMATINIB MESYLATE

Application Number

79179

Product Number

1

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2016-08-05

Regulatory Status

RX

2016
05 Aug
RX Application: 79179

Drug Name

IMATINIB MESYLATE

Product Number

2

Dosage Form

-

Strength

EQ 400MG BASE

Approval Date

2016-08-05

79179 / 2

Active Ingredient

IMATINIB MESYLATE

Application Number

79179

Product Number

2

Dosage Form

-

Strength

EQ 400MG BASE

Approval Date

2016-08-05

Regulatory Status

RX

2023
18 Aug
RX Application: 217110

Drug Name

IVRA

Product Number

1

Dosage Form

-

Strength

EQ 90MG BASE/ML (EQ 90MG BASE/ML)

Approval Date

2023-08-18

217110 / 1

Active Ingredient

MELPHALAN HYDROCHLORIDE

Application Number

217110

Product Number

1

Dosage Form

-

Strength

EQ 90MG BASE/ML (EQ 90MG BASE/ML)

Approval Date

2023-08-18

Regulatory Status

RX

2009
05 Nov
RX Application: 76109

Drug Name

KETOROLAC TROMETHAMINE

Product Number

1

Dosage Form

-

Strength

0.5%

Approval Date

2009-11-05

76109 / 1

Active Ingredient

KETOROLAC TROMETHAMINE

Application Number

76109

Product Number

1

Dosage Form

-

Strength

0.5%

Approval Date

2009-11-05

Regulatory Status

RX

2007
27 Mar
RX Application: 77942

Drug Name

KETOROLAC TROMETHAMINE

Product Number

1

Dosage Form

-

Strength

15MG/ML

Approval Date

2007-03-27

77942 / 1

Active Ingredient

KETOROLAC TROMETHAMINE

Application Number

77942

Product Number

1

Dosage Form

-

Strength

15MG/ML

Approval Date

2007-03-27

Regulatory Status

RX

2007
27 Mar
RX Application: 77942

Drug Name

KETOROLAC TROMETHAMINE

Product Number

2

Dosage Form

-

Strength

30MG/ML

Approval Date

2007-03-27

77942 / 2

Active Ingredient

KETOROLAC TROMETHAMINE

Application Number

77942

Product Number

2

Dosage Form

-

Strength

30MG/ML

Approval Date

2007-03-27

Regulatory Status

RX

2023
13 Nov
RX Application: 216670

Drug Name

LACOSAMIDE

Product Number

1

Dosage Form

-

Strength

200MG/20ML (10MG/ML)

Approval Date

2023-11-13

216670 / 1

Active Ingredient

LACOSAMIDE

Application Number

216670

Product Number

1

Dosage Form

-

Strength

200MG/20ML (10MG/ML)

Approval Date

2023-11-13

Regulatory Status

RX

1997
10 Dec
RX Application: 74712

Drug Name

LACTULOSE

Product Number

1

Dosage Form

-

Strength

10GM/PACKET

Approval Date

1997-12-10

74712 / 1

Active Ingredient

LACTULOSE

Application Number

74712

Product Number

1

Dosage Form

-

Strength

10GM/PACKET

Approval Date

1997-12-10

Regulatory Status

RX

1997
10 Dec
RX Application: 74712

Drug Name

LACTULOSE

Product Number

2

Dosage Form

-

Strength

20GM/PACKET

Approval Date

1997-12-10

74712 / 2

Active Ingredient

LACTULOSE

Application Number

74712

Product Number

2

Dosage Form

-

Strength

20GM/PACKET

Approval Date

1997-12-10

Regulatory Status

RX

2011
02 Dec
RX Application: 91606

Drug Name

LAMIVUDINE

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

2011-12-02

91606 / 1

Active Ingredient

LAMIVUDINE

Application Number

91606

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

2011-12-02

Regulatory Status

RX

2011
02 Dec
RX Application: 91606

Drug Name

LAMIVUDINE

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2011-12-02

91606 / 2

Active Ingredient

LAMIVUDINE

Application Number

91606

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2011-12-02

Regulatory Status

RX

2014
02 Jan
RX Application: 202941

Drug Name

LAMIVUDINE

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2014-01-02

202941 / 1

Active Ingredient

LAMIVUDINE

Application Number

202941

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2014-01-02

Regulatory Status

RX

2012
14 Sep
RX Application: 202176

Drug Name

LANSOPRAZOLE

Product Number

1

Dosage Form

-

Strength

15MG

Approval Date

2012-09-14

202176 / 1

Active Ingredient

LANSOPRAZOLE

Application Number

202176

Product Number

1

Dosage Form

-

Strength

15MG

Approval Date

2012-09-14

Regulatory Status

RX

2012
14 Sep
RX Application: 202176

Drug Name

LANSOPRAZOLE

Product Number

2

Dosage Form

-

Strength

30MG

Approval Date

2012-09-14

202176 / 2

Active Ingredient

LANSOPRAZOLE

Application Number

202176

Product Number

2

Dosage Form

-

Strength

30MG

Approval Date

2012-09-14

Regulatory Status

RX

2005
13 Sep
RX Application: 77090

Drug Name

LEFLUNOMIDE

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2005-09-13

77090 / 1

Active Ingredient

LEFLUNOMIDE

Application Number

77090

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2005-09-13

Regulatory Status

RX

2005
13 Sep
RX Application: 77090

Drug Name

LEFLUNOMIDE

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2005-09-13

77090 / 2

Active Ingredient

LEFLUNOMIDE

Application Number

77090

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2005-09-13

Regulatory Status

RX

2022
30 Aug
RX Application: 211022

Drug Name

LENALIDOMIDE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2022-08-30

211022 / 1

Active Ingredient

LENALIDOMIDE

Application Number

211022

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2022-08-30

Regulatory Status

RX

2022
30 Aug
RX Application: 211022

Drug Name

LENALIDOMIDE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2022-08-30

211022 / 2

Active Ingredient

LENALIDOMIDE

Application Number

211022

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2022-08-30

Regulatory Status

RX

2022
30 Aug
RX Application: 211022

Drug Name

LENALIDOMIDE

Product Number

3

Dosage Form

-

Strength

15MG

Approval Date

2022-08-30

211022 / 3

Active Ingredient

LENALIDOMIDE

Application Number

211022

Product Number

3

Dosage Form

-

Strength

15MG

Approval Date

2022-08-30

Regulatory Status

RX

2022
30 Aug
RX Application: 211022

Drug Name

LENALIDOMIDE

Product Number

4

Dosage Form

-

Strength

25MG

Approval Date

2022-08-30

211022 / 4

Active Ingredient

LENALIDOMIDE

Application Number

211022

Product Number

4

Dosage Form

-

Strength

25MG

Approval Date

2022-08-30

Regulatory Status

RX

2023
07 Mar
RX Application: 211022

Drug Name

LENALIDOMIDE

Product Number

5

Dosage Form

-

Strength

2.5MG

Approval Date

2023-03-07

211022 / 5

Active Ingredient

LENALIDOMIDE

Application Number

211022

Product Number

5

Dosage Form

-

Strength

2.5MG

Approval Date

2023-03-07

Regulatory Status

RX

2023
07 Mar
RX Application: 211022

Drug Name

LENALIDOMIDE

Product Number

6

Dosage Form

-

Strength

20MG

Approval Date

2023-03-07

211022 / 6

Active Ingredient

LENALIDOMIDE

Application Number

211022

Product Number

6

Dosage Form

-

Strength

20MG

Approval Date

2023-03-07

Regulatory Status

RX

2023
25 Aug
RX Application: 216944

Drug Name

LISDEXAMFETAMINE DIMESYLATE

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2023-08-25

216944 / 1

Active Ingredient

LISDEXAMFETAMINE DIMESYLATE

Application Number

216944

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2023-08-25

Regulatory Status

RX

2023
25 Aug
RX Application: 216944

Drug Name

LISDEXAMFETAMINE DIMESYLATE

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2023-08-25

216944 / 2

Active Ingredient

LISDEXAMFETAMINE DIMESYLATE

Application Number

216944

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2023-08-25

Regulatory Status

RX

2023
25 Aug
RX Application: 216944

Drug Name

LISDEXAMFETAMINE DIMESYLATE

Product Number

3

Dosage Form

-

Strength

30MG

Approval Date

2023-08-25

216944 / 3

Active Ingredient

LISDEXAMFETAMINE DIMESYLATE

Application Number

216944

Product Number

3

Dosage Form

-

Strength

30MG

Approval Date

2023-08-25

Regulatory Status

RX

2023
25 Aug
RX Application: 216944

Drug Name

LISDEXAMFETAMINE DIMESYLATE

Product Number

4

Dosage Form

-

Strength

40MG

Approval Date

2023-08-25

216944 / 4

Active Ingredient

LISDEXAMFETAMINE DIMESYLATE

Application Number

216944

Product Number

4

Dosage Form

-

Strength

40MG

Approval Date

2023-08-25

Regulatory Status

RX

2023
25 Aug
RX Application: 216944

Drug Name

LISDEXAMFETAMINE DIMESYLATE

Product Number

5

Dosage Form

-

Strength

50MG

Approval Date

2023-08-25

216944 / 5

Active Ingredient

LISDEXAMFETAMINE DIMESYLATE

Application Number

216944

Product Number

5

Dosage Form

-

Strength

50MG

Approval Date

2023-08-25

Regulatory Status

RX

2023
25 Aug
RX Application: 216944

Drug Name

LISDEXAMFETAMINE DIMESYLATE

Product Number

6

Dosage Form

-

Strength

60MG

Approval Date

2023-08-25

216944 / 6

Active Ingredient

LISDEXAMFETAMINE DIMESYLATE

Application Number

216944

Product Number

6

Dosage Form

-

Strength

60MG

Approval Date

2023-08-25

Regulatory Status

RX

2023
25 Aug
RX Application: 216944

Drug Name

LISDEXAMFETAMINE DIMESYLATE

Product Number

7

Dosage Form

-

Strength

70MG

Approval Date

2023-08-25

216944 / 7

Active Ingredient

LISDEXAMFETAMINE DIMESYLATE

Application Number

216944

Product Number

7

Dosage Form

-

Strength

70MG

Approval Date

2023-08-25

Regulatory Status

RX

2024
09 Jan
RX Application: 211195

Drug Name

MACITENTAN

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2024-01-09

211195 / 1

Active Ingredient

MACITENTAN

Application Number

211195

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2024-01-09

Regulatory Status

RX

2018
09 Feb
RX Application: 209955

Drug Name

MEMANTINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

2MG/ML

Approval Date

2018-02-09

209955 / 1

Active Ingredient

MEMANTINE HYDROCHLORIDE

Application Number

209955

Product Number

1

Dosage Form

-

Strength

2MG/ML

Approval Date

2018-02-09

Regulatory Status

RX

2006
12 Sep
RX Application: 77746

Drug Name

MIDODRINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2006-09-12

77746 / 1

Active Ingredient

MIDODRINE HYDROCHLORIDE

Application Number

77746

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2006-09-12

Regulatory Status

RX

2006
12 Sep
RX Application: 77746

Drug Name

MIDODRINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2006-09-12

77746 / 2

Active Ingredient

MIDODRINE HYDROCHLORIDE

Application Number

77746

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2006-09-12

Regulatory Status

RX

2006
12 Sep
RX Application: 77746

Drug Name

MIDODRINE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

2006-09-12

77746 / 3

Active Ingredient

MIDODRINE HYDROCHLORIDE

Application Number

77746

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

2006-09-12

Regulatory Status

RX

2007
22 Aug
RX Application: 77666

Drug Name

MIRTAZAPINE

Product Number

1

Dosage Form

-

Strength

15MG

Approval Date

2007-08-22

77666 / 1

Active Ingredient

MIRTAZAPINE

Application Number

77666

Product Number

1

Dosage Form

-

Strength

15MG

Approval Date

2007-08-22

Regulatory Status

RX

2007
22 Aug
RX Application: 77666

Drug Name

MIRTAZAPINE

Product Number

2

Dosage Form

-

Strength

30MG

Approval Date

2007-08-22

77666 / 2

Active Ingredient

MIRTAZAPINE

Application Number

77666

Product Number

2

Dosage Form

-

Strength

30MG

Approval Date

2007-08-22

Regulatory Status

RX

2007
22 Aug
RX Application: 77666

Drug Name

MIRTAZAPINE

Product Number

3

Dosage Form

-

Strength

45MG

Approval Date

2007-08-22

77666 / 3

Active Ingredient

MIRTAZAPINE

Application Number

77666

Product Number

3

Dosage Form

-

Strength

45MG

Approval Date

2007-08-22

Regulatory Status

RX

2014
03 Feb
RX Application: 77667

Drug Name

MODAFINIL

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2014-02-03

77667 / 1

Active Ingredient

MODAFINIL

Application Number

77667

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2014-02-03

Regulatory Status

RX

2014
03 Feb
RX Application: 77667

Drug Name

MODAFINIL

Product Number

2

Dosage Form

-

Strength

200MG

Approval Date

2014-02-03

77667 / 2

Active Ingredient

MODAFINIL

Application Number

77667

Product Number

2

Dosage Form

-

Strength

200MG

Approval Date

2014-02-03

Regulatory Status

RX

2016
22 Mar
RX Application: 91161

Drug Name

MOMETASONE FUROATE

Product Number

1

Dosage Form

-

Strength

0.05MG/SPRAY

Approval Date

2016-03-22

91161 / 1

Active Ingredient

MOMETASONE FUROATE

Application Number

91161

Product Number

1

Dosage Form

-

Strength

0.05MG/SPRAY

Approval Date

2016-03-22

Regulatory Status

RX

2017
30 Jun
RX Application: 90080

Drug Name

MOXIFLOXACIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 0.5% BASE

Approval Date

2017-06-30

90080 / 1

Active Ingredient

MOXIFLOXACIN HYDROCHLORIDE

Application Number

90080

Product Number

1

Dosage Form

-

Strength

EQ 0.5% BASE

Approval Date

2017-06-30

Regulatory Status

RX

2026
09 Apr
RX Application: 210273

Drug Name

MULTIPLE VITAMINS INJECTION ADULT

Product Number

1

Dosage Form

-

Strength

2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML

Approval Date

2026-04-09

210273 / 1

Active Ingredient

ALPHA-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE; VITAMIN K

Application Number

210273

Product Number

1

Dosage Form

-

Strength

2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML

Approval Date

2026-04-09

Regulatory Status

RX

2026
09 Apr
RX Application: 210672

Drug Name

MULTIPLE VITAMINS INJECTION ADULT

Product Number

1

Dosage Form

-

Strength

2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML

Approval Date

2026-04-09

210672 / 1

Active Ingredient

ALPHA-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE; VITAMIN K

Application Number

210672

Product Number

1

Dosage Form

-

Strength

2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML

Approval Date

2026-04-09

Regulatory Status

RX

2026
21 Apr
RX Application: 210671

Drug Name

MULTIPLE VITAMINS INJECTION PEDIATRIC

Product Number

1

Dosage Form

-

Strength

80MG/VIAL;0.02MG/VIAL;400 IU/VIAL;0.001MG/VIAL;5MG/VIAL;0.14MG/VIAL;17MG/VIAL;1MG/VIAL;1.4MG/VIAL;1.2MG/VIAL;7 IU/VIAL;2,300 IU/VIAL;0.2MG/VIAL

Approval Date

2026-04-21

210671 / 1

Active Ingredient

ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; TOCOPHEROL ACETATE; VITAMIN A; VITAMIN K

Application Number

210671

Product Number

1

Dosage Form

-

Strength

80MG/VIAL;0.02MG/VIAL;400 IU/VIAL;0.001MG/VIAL;5MG/VIAL;0.14MG/VIAL;17MG/VIAL;1MG/VIAL;1.4MG/VIAL;1.2MG/VIAL;7 IU/VIAL;2,300 IU/VIAL;0.2MG/VIAL

Approval Date

2026-04-21

Regulatory Status

RX

2026
21 Apr
RX Application: 210456

Drug Name

MULTIPLE VITAMINS INJECTION PEDIATRIC (PHARMACY BULK PACKAGE)

Product Number

1

Dosage Form

-

Strength

80MG/VIAL;0.02MG/VIAL;400 IU/VIAL;0.001MG/VIAL;5MG/VIAL;0.14MG/VIAL;17MG/VIAL;1MG/VIAL;1.4MG/VIAL;1.2MG/VIAL;7 IU/VIAL;2,300 IU/VIAL;0.2MG/VIAL

Approval Date

2026-04-21

210456 / 1

Active Ingredient

ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; TOCOPHEROL ACETATE; VITAMIN A; VITAMIN K

Application Number

210456

Product Number

1

Dosage Form

-

Strength

80MG/VIAL;0.02MG/VIAL;400 IU/VIAL;0.001MG/VIAL;5MG/VIAL;0.14MG/VIAL;17MG/VIAL;1MG/VIAL;1.4MG/VIAL;1.2MG/VIAL;7 IU/VIAL;2,300 IU/VIAL;0.2MG/VIAL

Approval Date

2026-04-21

Regulatory Status

RX

2024
05 Jan
RX Application: 203640

Drug Name

NILOTINIB HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

2024-01-05

203640 / 1

Active Ingredient

NILOTINIB HYDROCHLORIDE

Application Number

203640

Product Number

1

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

2024-01-05

Regulatory Status

RX

2024
05 Jan
RX Application: 203640

Drug Name

NILOTINIB HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2024-01-05

203640 / 2

Active Ingredient

NILOTINIB HYDROCHLORIDE

Application Number

203640

Product Number

2

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2024-01-05

Regulatory Status

RX

2024
05 Jan
RX Application: 203640

Drug Name

NILOTINIB HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

EQ 200MG BASE

Approval Date

2024-01-05

203640 / 3

Active Ingredient

NILOTINIB HYDROCHLORIDE

Application Number

203640

Product Number

3

Dosage Form

-

Strength

EQ 200MG BASE

Approval Date

2024-01-05

Regulatory Status

RX

2026
02 Apr
RX Application: 219227

Drug Name

NINTEDANIB ESYLATE

Product Number

1

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2026-04-02

219227 / 1

Active Ingredient

NINTEDANIB ESYLATE

Application Number

219227

Product Number

1

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2026-04-02

Regulatory Status

RX

2026
02 Apr
RX Application: 219227

Drug Name

NINTEDANIB ESYLATE

Product Number

2

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2026-04-02

219227 / 2

Active Ingredient

NINTEDANIB ESYLATE

Application Number

219227

Product Number

2

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2026-04-02

Regulatory Status

RX

2007
22 Oct
RX Application: 76048

Drug Name

OMEPRAZOLE

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2007-10-22

76048 / 1

Active Ingredient

OMEPRAZOLE

Application Number

76048

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2007-10-22

Regulatory Status

RX

2007
22 Oct
RX Application: 76048

Drug Name

OMEPRAZOLE

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2007-10-22

76048 / 2

Active Ingredient

OMEPRAZOLE

Application Number

76048

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2007-10-22

Regulatory Status

RX

2009
21 Jan
RX Application: 76048

Drug Name

OMEPRAZOLE

Product Number

3

Dosage Form

-

Strength

40MG

Approval Date

2009-01-21

76048 / 3

Active Ingredient

OMEPRAZOLE

Application Number

76048

Product Number

3

Dosage Form

-

Strength

40MG

Approval Date

2009-01-21

Regulatory Status

RX

2023
13 Jul
RX Application: 213369

Drug Name

OXCARBAZEPINE

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

2023-07-13

213369 / 1

Active Ingredient

OXCARBAZEPINE

Application Number

213369

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

2023-07-13

Regulatory Status

RX

2023
13 Jul
RX Application: 213369

Drug Name

OXCARBAZEPINE

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2023-07-13

213369 / 2

Active Ingredient

OXCARBAZEPINE

Application Number

213369

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2023-07-13

Regulatory Status

RX

2023
13 Jul
RX Application: 213369

Drug Name

OXCARBAZEPINE

Product Number

3

Dosage Form

-

Strength

600MG

Approval Date

2023-07-13

213369 / 3

Active Ingredient

OXCARBAZEPINE

Application Number

213369

Product Number

3

Dosage Form

-

Strength

600MG

Approval Date

2023-07-13

Regulatory Status

RX

2011
19 Jan
RX Application: 91231

Drug Name

PANTOPRAZOLE SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2011-01-19

91231 / 1

Active Ingredient

PANTOPRAZOLE SODIUM

Application Number

91231

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2011-01-19

Regulatory Status

RX

2011
19 Jan
RX Application: 91231

Drug Name

PANTOPRAZOLE SODIUM

Product Number

2

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2011-01-19

91231 / 2

Active Ingredient

PANTOPRAZOLE SODIUM

Application Number

91231

Product Number

2

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2011-01-19

Regulatory Status

RX

2003
30 Jul
RX Application: 75356

Drug Name

PAROXETINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2003-07-30

75356 / 1

Active Ingredient

PAROXETINE HYDROCHLORIDE

Application Number

75356

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2003-07-30

Regulatory Status

RX

2003
30 Jul
RX Application: 75356

Drug Name

PAROXETINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2003-07-30

75356 / 2

Active Ingredient

PAROXETINE HYDROCHLORIDE

Application Number

75356

Product Number

2

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2003-07-30

Regulatory Status

RX

2003
30 Jul
RX Application: 75356

Drug Name

PAROXETINE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

EQ 30MG BASE

Approval Date

2003-07-30

75356 / 3

Active Ingredient

PAROXETINE HYDROCHLORIDE

Application Number

75356

Product Number

3

Dosage Form

-

Strength

EQ 30MG BASE

Approval Date

2003-07-30

Regulatory Status

RX

2003
30 Jul
RX Application: 75356

Drug Name

PAROXETINE HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2003-07-30

75356 / 4

Active Ingredient

PAROXETINE HYDROCHLORIDE

Application Number

75356

Product Number

4

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2003-07-30

Regulatory Status

RX

1992
29 Dec
RX Application: 20031

Drug Name

PAXIL

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

1992-12-29

20031 / 1

Active Ingredient

PAROXETINE HYDROCHLORIDE

Application Number

20031

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

1992-12-29

Regulatory Status

RX

1992
29 Dec
RX Application: 20031

Drug Name

PAXIL

Product Number

2

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

1992-12-29

20031 / 2

Active Ingredient

PAROXETINE HYDROCHLORIDE

Application Number

20031

Product Number

2

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

1992-12-29

Regulatory Status

RX

1992
29 Dec
RX Application: 20031

Drug Name

PAXIL

Product Number

3

Dosage Form

-

Strength

EQ 30MG BASE

Approval Date

1992-12-29

20031 / 3

Active Ingredient

PAROXETINE HYDROCHLORIDE

Application Number

20031

Product Number

3

Dosage Form

-

Strength

EQ 30MG BASE

Approval Date

1992-12-29

Regulatory Status

RX

1992
29 Dec
RX Application: 20031

Drug Name

PAXIL

Product Number

5

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

1992-12-29

20031 / 5

Active Ingredient

PAROXETINE HYDROCHLORIDE

Application Number

20031

Product Number

5

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

1992-12-29

Regulatory Status

RX

1999
16 Feb
RX Application: 20936

Drug Name

PAXIL CR

Product Number

1

Dosage Form

-

Strength

EQ 12.5MG BASE

Approval Date

1999-02-16

20936 / 1

Active Ingredient

PAROXETINE HYDROCHLORIDE

Application Number

20936

Product Number

1

Dosage Form

-

Strength

EQ 12.5MG BASE

Approval Date

1999-02-16

Regulatory Status

RX

1999
16 Feb
RX Application: 20936

Drug Name

PAXIL CR

Product Number

2

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

1999-02-16

20936 / 2

Active Ingredient

PAROXETINE HYDROCHLORIDE

Application Number

20936

Product Number

2

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

1999-02-16

Regulatory Status

RX

2000
06 Dec
RX Application: 20936

Drug Name

PAXIL CR

Product Number

3

Dosage Form

-

Strength

EQ 37.5MG BASE

Approval Date

2000-12-06

20936 / 3

Active Ingredient

PAROXETINE HYDROCHLORIDE

Application Number

20936

Product Number

3

Dosage Form

-

Strength

EQ 37.5MG BASE

Approval Date

2000-12-06

Regulatory Status

RX

2023
19 Oct
RX Application: 217713

Drug Name

PAZOPANIB HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 200MG BASE

Approval Date

2023-10-19

217713 / 1

Active Ingredient

PAZOPANIB HYDROCHLORIDE

Application Number

217713

Product Number

1

Dosage Form

-

Strength

EQ 200MG BASE

Approval Date

2023-10-19

Regulatory Status

RX

2022
25 May
RX Application: 203774

Drug Name

PEMETREXED DISODIUM

Product Number

1

Dosage Form

-

Strength

EQ 100MG BASE/VIAL

Approval Date

2022-05-25

203774 / 1

Active Ingredient

PEMETREXED DISODIUM

Application Number

203774

Product Number

1

Dosage Form

-

Strength

EQ 100MG BASE/VIAL

Approval Date

2022-05-25

Regulatory Status

RX

2022
25 May
RX Application: 203774

Drug Name

PEMETREXED DISODIUM

Product Number

2

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

Approval Date

2022-05-25

203774 / 2

Active Ingredient

PEMETREXED DISODIUM

Application Number

203774

Product Number

2

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

Approval Date

2022-05-25

Regulatory Status

RX

2022
25 May
RX Application: 209851

Drug Name

PEMETREXED DISODIUM

Product Number

1

Dosage Form

-

Strength

EQ 750MG BASE/VIAL

Approval Date

2022-05-25

209851 / 1

Active Ingredient

PEMETREXED DISODIUM

Application Number

209851

Product Number

1

Dosage Form

-

Strength

EQ 750MG BASE/VIAL

Approval Date

2022-05-25

Regulatory Status

RX

1999
09 Jun
RX Application: 75191

Drug Name

PENTOXIFYLLINE

Product Number

1

Dosage Form

-

Strength

400MG

Approval Date

1999-06-09

75191 / 1

Active Ingredient

PENTOXIFYLLINE

Application Number

75191

Product Number

1

Dosage Form

-

Strength

400MG

Approval Date

1999-06-09

Regulatory Status

RX

2017
22 Mar
RX Application: 206996

Drug Name

PIPERACILLIN AND TAZOBACTAM

Product Number

1

Dosage Form

-

Strength

EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL

Approval Date

2017-03-22

206996 / 1

Active Ingredient

PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Application Number

206996

Product Number

1

Dosage Form

-

Strength

EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL

Approval Date

2017-03-22

Regulatory Status

RX

2017
22 Mar
RX Application: 206996

Drug Name

PIPERACILLIN AND TAZOBACTAM

Product Number

2

Dosage Form

-

Strength

EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL

Approval Date

2017-03-22

206996 / 2

Active Ingredient

PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Application Number

206996

Product Number

2

Dosage Form

-

Strength

EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL

Approval Date

2017-03-22

Regulatory Status

RX

2017
22 Mar
RX Application: 206996

Drug Name

PIPERACILLIN AND TAZOBACTAM

Product Number

3

Dosage Form

-

Strength

EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL

Approval Date

2017-03-22

206996 / 3

Active Ingredient

PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Application Number

206996

Product Number

3

Dosage Form

-

Strength

EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL

Approval Date

2017-03-22

Regulatory Status

RX

2017
17 Mar
RX Application: 207146

Drug Name

PIPERACILLIN AND TAZOBACTAM

Product Number

1

Dosage Form

-

Strength

EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL

Approval Date

2017-03-17

207146 / 1

Active Ingredient

PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Application Number

207146

Product Number

1

Dosage Form

-

Strength

EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL

Approval Date

2017-03-17

Regulatory Status

RX

2023
31 May
RX Application: 212709

Drug Name

PIRFENIDONE

Product Number

1

Dosage Form

-

Strength

267MG

Approval Date

2023-05-31

212709 / 1

Active Ingredient

PIRFENIDONE

Application Number

212709

Product Number

1

Dosage Form

-

Strength

267MG

Approval Date

2023-05-31

Regulatory Status

RX

2023
31 May
RX Application: 212709

Drug Name

PIRFENIDONE

Product Number

2

Dosage Form

-

Strength

801MG

Approval Date

2023-05-31

212709 / 2

Active Ingredient

PIRFENIDONE

Application Number

212709

Product Number

2

Dosage Form

-

Strength

801MG

Approval Date

2023-05-31

Regulatory Status

RX

2024
11 Jun
RX Application: 210164

Drug Name

POMALIDOMIDE

Product Number

1

Dosage Form

-

Strength

1MG

Approval Date

2024-06-11

210164 / 1

Active Ingredient

POMALIDOMIDE

Application Number

210164

Product Number

1

Dosage Form

-

Strength

1MG

Approval Date

2024-06-11

Regulatory Status

RX

2024
11 Jun
RX Application: 210164

Drug Name

POMALIDOMIDE

Product Number

2

Dosage Form

-

Strength

2MG

Approval Date

2024-06-11

210164 / 2

Active Ingredient

POMALIDOMIDE

Application Number

210164

Product Number

2

Dosage Form

-

Strength

2MG

Approval Date

2024-06-11

Regulatory Status

RX

2024
11 Jun
RX Application: 210164

Drug Name

POMALIDOMIDE

Product Number

3

Dosage Form

-

Strength

3MG

Approval Date

2024-06-11

210164 / 3

Active Ingredient

POMALIDOMIDE

Application Number

210164

Product Number

3

Dosage Form

-

Strength

3MG

Approval Date

2024-06-11

Regulatory Status

RX

2024
11 Jun
RX Application: 210164

Drug Name

POMALIDOMIDE

Product Number

4

Dosage Form

-

Strength

4MG

Approval Date

2024-06-11

210164 / 4

Active Ingredient

POMALIDOMIDE

Application Number

210164

Product Number

4

Dosage Form

-

Strength

4MG

Approval Date

2024-06-11

Regulatory Status

RX

2026
29 Jun
RX Application: 213331

Drug Name

POSACONAZOLE

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2026-06-29

213331 / 1

Active Ingredient

POSACONAZOLE

Application Number

213331

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2026-06-29

Regulatory Status

RX

2006
23 Oct
RX Application: 76341

Drug Name

PRAVASTATIN SODIUM

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2006-10-23

76341 / 1

Active Ingredient

PRAVASTATIN SODIUM

Application Number

76341

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2006-10-23

Regulatory Status

RX

2006
23 Oct
RX Application: 76341

Drug Name

PRAVASTATIN SODIUM

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2006-10-23

76341 / 2

Active Ingredient

PRAVASTATIN SODIUM

Application Number

76341

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2006-10-23

Regulatory Status

RX

2006
23 Oct
RX Application: 76341

Drug Name

PRAVASTATIN SODIUM

Product Number

3

Dosage Form

-

Strength

40MG

Approval Date

2006-10-23

76341 / 3

Active Ingredient

PRAVASTATIN SODIUM

Application Number

76341

Product Number

3

Dosage Form

-

Strength

40MG

Approval Date

2006-10-23

Regulatory Status

RX

2007
28 Dec
RX Application: 76341

Drug Name

PRAVASTATIN SODIUM

Product Number

4

Dosage Form

-

Strength

80MG

Approval Date

2007-12-28

76341 / 4

Active Ingredient

PRAVASTATIN SODIUM

Application Number

76341

Product Number

4

Dosage Form

-

Strength

80MG

Approval Date

2007-12-28

Regulatory Status

RX

2025
24 Jun
RX Application: 218977

Drug Name

PRUCALOPRIDE SUCCINATE

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2025-06-24

218977 / 1

Active Ingredient

PRUCALOPRIDE SUCCINATE

Application Number

218977

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2025-06-24

Regulatory Status

RX

2025
24 Jun
RX Application: 218977

Drug Name

PRUCALOPRIDE SUCCINATE

Product Number

2

Dosage Form

-

Strength

EQ 2MG BASE

Approval Date

2025-06-24

218977 / 2

Active Ingredient

PRUCALOPRIDE SUCCINATE

Application Number

218977

Product Number

2

Dosage Form

-

Strength

EQ 2MG BASE

Approval Date

2025-06-24

Regulatory Status

RX

2022
11 Apr
RX Application: 207604

Drug Name

REGADENOSON

Product Number

1

Dosage Form

-

Strength

0.4MG/5ML (0.08MG/ML)

Approval Date

2022-04-11

207604 / 1

Active Ingredient

REGADENOSON

Application Number

207604

Product Number

1

Dosage Form

-

Strength

0.4MG/5ML (0.08MG/ML)

Approval Date

2022-04-11

Regulatory Status

RX

2015
30 Nov
RX Application: 90877

Drug Name

RISEDRONATE SODIUM

Product Number

1

Dosage Form

-

Strength

35MG

Approval Date

2015-11-30

90877 / 1

Active Ingredient

RISEDRONATE SODIUM

Application Number

90877

Product Number

1

Dosage Form

-

Strength

35MG

Approval Date

2015-11-30

Regulatory Status

RX

2014
10 Jun
RX Application: 90877

Drug Name

RISEDRONATE SODIUM

Product Number

2

Dosage Form

-

Strength

75MG

Approval Date

2014-06-10

90877 / 2

Active Ingredient

RISEDRONATE SODIUM

Application Number

90877

Product Number

2

Dosage Form

-

Strength

75MG

Approval Date

2014-06-10

Regulatory Status

RX

2014
10 Jun
RX Application: 90877

Drug Name

RISEDRONATE SODIUM

Product Number

3

Dosage Form

-

Strength

150MG

Approval Date

2014-06-10

90877 / 3

Active Ingredient

RISEDRONATE SODIUM

Application Number

90877

Product Number

3

Dosage Form

-

Strength

150MG

Approval Date

2014-06-10

Regulatory Status

RX

2025
02 May
RX Application: 217810

Drug Name

RIVAROXABAN

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2025-05-02

217810 / 1

Active Ingredient

RIVAROXABAN

Application Number

217810

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2025-05-02

Regulatory Status

RX

2026
02 Mar
RX Application: 218427

Drug Name

RIVAROXABAN

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

2026-03-02

218427 / 1

Active Ingredient

RIVAROXABAN

Application Number

218427

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

2026-03-02

Regulatory Status

RX

2008
12 Sep
RX Application: 22198

Drug Name

SANCUSO

Product Number

1

Dosage Form

-

Strength

3.1MG/24HR

Approval Date

2008-09-12

22198 / 1

Active Ingredient

GRANISETRON

Application Number

22198

Product Number

1

Dosage Form

-

Strength

3.1MG/24HR

Approval Date

2008-09-12

Regulatory Status

RX

1997
06 Jun
RX Application: 74871

Drug Name

SELEGILINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

1997-06-06

74871 / 1

Active Ingredient

SELEGILINE HYDROCHLORIDE

Application Number

74871

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

1997-06-06

Regulatory Status

RX

1998
04 Dec
RX Application: 75321

Drug Name

SELEGILINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

1998-12-04

75321 / 1

Active Ingredient

SELEGILINE HYDROCHLORIDE

Application Number

75321

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

1998-12-04

Regulatory Status

RX

2019
22 Oct
RX Application: 211406

Drug Name

SIROLIMUS

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

2019-10-22

211406 / 1

Active Ingredient

SIROLIMUS

Application Number

211406

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

2019-10-22

Regulatory Status

RX

2026
30 Apr
RX Application: 202426

Drug Name

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

500MG;EQ 50MG BASE

Approval Date

2026-04-30

202426 / 1

Active Ingredient

METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE

Application Number

202426

Product Number

1

Dosage Form

-

Strength

500MG;EQ 50MG BASE

Approval Date

2026-04-30

Regulatory Status

RX

2026
30 Apr
RX Application: 202426

Drug Name

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

1GM;EQ 50MG BASE

Approval Date

2026-04-30

202426 / 2

Active Ingredient

METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE

Application Number

202426

Product Number

2

Dosage Form

-

Strength

1GM;EQ 50MG BASE

Approval Date

2026-04-30

Regulatory Status

RX

2026
20 Jan
RX Application: 202425

Drug Name

SITAGLIPTIN PHOSPHATE

Product Number

1

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

2026-01-20

202425 / 1

Active Ingredient

SITAGLIPTIN PHOSPHATE

Application Number

202425

Product Number

1

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

2026-01-20

Regulatory Status

RX

2026
20 Jan
RX Application: 202425

Drug Name

SITAGLIPTIN PHOSPHATE

Product Number

2

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

2026-01-20

202425 / 2

Active Ingredient

SITAGLIPTIN PHOSPHATE

Application Number

202425

Product Number

2

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

2026-01-20

Regulatory Status

RX

2026
20 Jan
RX Application: 202425

Drug Name

SITAGLIPTIN PHOSPHATE

Product Number

3

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2026-01-20

202425 / 3

Active Ingredient

SITAGLIPTIN PHOSPHATE

Application Number

202425

Product Number

3

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2026-01-20

Regulatory Status

RX

2002
26 Sep
RX Application: 76140

Drug Name

SOTALOL HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

80MG

Approval Date

2002-09-26

76140 / 1

Active Ingredient

SOTALOL HYDROCHLORIDE

Application Number

76140

Product Number

1

Dosage Form

-

Strength

80MG

Approval Date

2002-09-26

Regulatory Status

RX

2002
26 Sep
RX Application: 76140

Drug Name

SOTALOL HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

120MG

Approval Date

2002-09-26

76140 / 2

Active Ingredient

SOTALOL HYDROCHLORIDE

Application Number

76140

Product Number

2

Dosage Form

-

Strength

120MG

Approval Date

2002-09-26

Regulatory Status

RX

2002
26 Sep
RX Application: 76140

Drug Name

SOTALOL HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

160MG

Approval Date

2002-09-26

76140 / 3

Active Ingredient

SOTALOL HYDROCHLORIDE

Application Number

76140

Product Number

3

Dosage Form

-

Strength

160MG

Approval Date

2002-09-26

Regulatory Status

RX

2002
26 Sep
RX Application: 76140

Drug Name

SOTALOL HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

240MG

Approval Date

2002-09-26

76140 / 4

Active Ingredient

SOTALOL HYDROCHLORIDE

Application Number

76140

Product Number

4

Dosage Form

-

Strength

240MG

Approval Date

2002-09-26

Regulatory Status

RX

2003
27 Aug
RX Application: 76214

Drug Name

SOTALOL HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

80MG

Approval Date

2003-08-27

76214 / 1

Active Ingredient

SOTALOL HYDROCHLORIDE

Application Number

76214

Product Number

1

Dosage Form

-

Strength

80MG

Approval Date

2003-08-27

Regulatory Status

RX

2003
27 Aug
RX Application: 76214

Drug Name

SOTALOL HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

120MG

Approval Date

2003-08-27

76214 / 2

Active Ingredient

SOTALOL HYDROCHLORIDE

Application Number

76214

Product Number

2

Dosage Form

-

Strength

120MG

Approval Date

2003-08-27

Regulatory Status

RX

2003
27 Aug
RX Application: 76214

Drug Name

SOTALOL HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

160MG

Approval Date

2003-08-27

76214 / 3

Active Ingredient

SOTALOL HYDROCHLORIDE

Application Number

76214

Product Number

3

Dosage Form

-

Strength

160MG

Approval Date

2003-08-27

Regulatory Status

RX

2022
20 Dec
RX Application: 211607

Drug Name

TASIMELTEON

Product Number

1

Dosage Form

-

Strength

20MG

Approval Date

2022-12-20

211607 / 1

Active Ingredient

TASIMELTEON

Application Number

211607

Product Number

1

Dosage Form

-

Strength

20MG

Approval Date

2022-12-20

Regulatory Status

RX

2023
16 Nov
RX Application: 211097

Drug Name

TERIPARATIDE

Product Number

1

Dosage Form

-

Strength

0.56MG/2.24ML (0.25MG/ML)

Approval Date

2023-11-16

211097 / 1

Active Ingredient

TERIPARATIDE

Application Number

211097

Product Number

1

Dosage Form

-

Strength

0.56MG/2.24ML (0.25MG/ML)

Approval Date

2023-11-16

Regulatory Status

RX

2020
17 Mar
RX Application: 206093

Drug Name

TETRABENAZINE

Product Number

1

Dosage Form

-

Strength

12.5MG

Approval Date

2020-03-17

206093 / 1

Active Ingredient

TETRABENAZINE

Application Number

206093

Product Number

1

Dosage Form

-

Strength

12.5MG

Approval Date

2020-03-17

Regulatory Status

RX

2020
17 Mar
RX Application: 206093

Drug Name

TETRABENAZINE

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

2020-03-17

206093 / 2

Active Ingredient

TETRABENAZINE

Application Number

206093

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

2020-03-17

Regulatory Status

RX

2025
01 May
RX Application: 208584

Drug Name

TICAGRELOR

Product Number

1

Dosage Form

-

Strength

90MG

Approval Date

2025-05-01

208584 / 1

Active Ingredient

TICAGRELOR

Application Number

208584

Product Number

1

Dosage Form

-

Strength

90MG

Approval Date

2025-05-01

Regulatory Status

RX

2025
28 Oct
RX Application: 208584

Drug Name

TICAGRELOR

Product Number

2

Dosage Form

-

Strength

60MG

Approval Date

2025-10-28

208584 / 2

Active Ingredient

TICAGRELOR

Application Number

208584

Product Number

2

Dosage Form

-

Strength

60MG

Approval Date

2025-10-28

Regulatory Status

RX

2018
21 Dec
RX Application: 204439

Drug Name

TIGECYCLINE

Product Number

1

Dosage Form

-

Strength

50MG/VIAL

Approval Date

2018-12-21

204439 / 1

Active Ingredient

TIGECYCLINE

Application Number

204439

Product Number

1

Dosage Form

-

Strength

50MG/VIAL

Approval Date

2018-12-21

Regulatory Status

RX

2004
16 Jan
RX Application: 76533

Drug Name

TIZANIDINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 2MG BASE

Approval Date

2004-01-16

76533 / 1

Active Ingredient

TIZANIDINE HYDROCHLORIDE

Application Number

76533

Product Number

1

Dosage Form

-

Strength

EQ 2MG BASE

Approval Date

2004-01-16

Regulatory Status

RX

2004
16 Jan
RX Application: 76533

Drug Name

TIZANIDINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 4MG BASE

Approval Date

2004-01-16

76533 / 2

Active Ingredient

TIZANIDINE HYDROCHLORIDE

Application Number

76533

Product Number

2

Dosage Form

-

Strength

EQ 4MG BASE

Approval Date

2004-01-16

Regulatory Status

RX

2026
03 Jun
RX Application: 218096

Drug Name

TOFACITINIB CITRATE

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2026-06-03

218096 / 1

Active Ingredient

TOFACITINIB CITRATE

Application Number

218096

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2026-06-03

Regulatory Status

RX

2026
03 Jun
RX Application: 218096

Drug Name

TOFACITINIB CITRATE

Product Number

2

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2026-06-03

218096 / 2

Active Ingredient

TOFACITINIB CITRATE

Application Number

218096

Product Number

2

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2026-06-03

Regulatory Status

RX

2026
03 Jun
RX Application: 220458

Drug Name

TOFACITINIB CITRATE

Product Number

1

Dosage Form

-

Strength

EQ 11MG BASE

Approval Date

2026-06-03

220458 / 1

Active Ingredient

TOFACITINIB CITRATE

Application Number

220458

Product Number

1

Dosage Form

-

Strength

EQ 11MG BASE

Approval Date

2026-06-03

Regulatory Status

RX

2020
19 May
RX Application: 207605

Drug Name

TOLVAPTAN

Product Number

1

Dosage Form

-

Strength

30MG

Approval Date

2020-05-19

207605 / 1

Active Ingredient

TOLVAPTAN

Application Number

207605

Product Number

1

Dosage Form

-

Strength

30MG

Approval Date

2020-05-19

Regulatory Status

RX

2022
06 Sep
RX Application: 207605

Drug Name

TOLVAPTAN

Product Number

2

Dosage Form

-

Strength

15MG

Approval Date

2022-09-06

207605 / 2

Active Ingredient

TOLVAPTAN

Application Number

207605

Product Number

2

Dosage Form

-

Strength

15MG

Approval Date

2022-09-06

Regulatory Status

RX

2025
10 Nov
RX Application: 218381

Drug Name

TOLVAPTAN

Product Number

1

Dosage Form

-

Strength

15MG

Approval Date

2025-11-10

218381 / 1

Active Ingredient

TOLVAPTAN

Application Number

218381

Product Number

1

Dosage Form

-

Strength

15MG

Approval Date

2025-11-10

Regulatory Status

RX

2025
10 Nov
RX Application: 218381

Drug Name

TOLVAPTAN

Product Number

2

Dosage Form

-

Strength

30MG

Approval Date

2025-11-10

218381 / 2

Active Ingredient

TOLVAPTAN

Application Number

218381

Product Number

2

Dosage Form

-

Strength

30MG

Approval Date

2025-11-10

Regulatory Status

RX

2025
10 Nov
RX Application: 218381

Drug Name

TOLVAPTAN

Product Number

3

Dosage Form

-

Strength

45MG

Approval Date

2025-11-10

218381 / 3

Active Ingredient

TOLVAPTAN

Application Number

218381

Product Number

3

Dosage Form

-

Strength

45MG

Approval Date

2025-11-10

Regulatory Status

RX

2025
10 Nov
RX Application: 218381

Drug Name

TOLVAPTAN

Product Number

4

Dosage Form

-

Strength

60MG

Approval Date

2025-11-10

218381 / 4

Active Ingredient

TOLVAPTAN

Application Number

218381

Product Number

4

Dosage Form

-

Strength

60MG

Approval Date

2025-11-10

Regulatory Status

RX

2025
10 Nov
RX Application: 218381

Drug Name

TOLVAPTAN

Product Number

5

Dosage Form

-

Strength

90MG

Approval Date

2025-11-10

218381 / 5

Active Ingredient

TOLVAPTAN

Application Number

218381

Product Number

5

Dosage Form

-

Strength

90MG

Approval Date

2025-11-10

Regulatory Status

RX

2020
14 Jan
RX Application: 209860

Drug Name

TRANEXAMIC ACID

Product Number

1

Dosage Form

-

Strength

100MG/ML

Approval Date

2020-01-14

209860 / 1

Active Ingredient

TRANEXAMIC ACID

Application Number

209860

Product Number

1

Dosage Form

-

Strength

100MG/ML

Approval Date

2020-01-14

Regulatory Status

RX

2015
10 Jul
RX Application: 203431

Drug Name

TRAVOPROST

Product Number

1

Dosage Form

-

Strength

0.004%

Approval Date

2015-07-10

203431 / 1

Active Ingredient

TRAVOPROST

Application Number

203431

Product Number

1

Dosage Form

-

Strength

0.004%

Approval Date

2015-07-10

Regulatory Status

RX

1987
25 Mar
RX Application: 71258

Drug Name

TRAZODONE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

1987-03-25

71258 / 1

Active Ingredient

TRAZODONE HYDROCHLORIDE

Application Number

71258

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

1987-03-25

Regulatory Status

RX

2011
06 Dec
RX Application: 91513

Drug Name

TROSPIUM CHLORIDE

Product Number

1

Dosage Form

-

Strength

20MG

Approval Date

2011-12-06

91513 / 1

Active Ingredient

TROSPIUM CHLORIDE

Application Number

91513

Product Number

1

Dosage Form

-

Strength

20MG

Approval Date

2011-12-06

Regulatory Status

RX

2008
08 Oct
RX Application: 21697

Drug Name

VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER

Product Number

2

Dosage Form

-

Strength

20MG/100ML (0.2MG/ML)

Approval Date

2008-10-08

21697 / 2

Active Ingredient

CONIVAPTAN HYDROCHLORIDE

Application Number

21697

Product Number

2

Dosage Form

-

Strength

20MG/100ML (0.2MG/ML)

Approval Date

2008-10-08

Regulatory Status

RX

2023
25 Jan
RX Application: 201962

Drug Name

VARENICLINE TARTRATE

Product Number

1

Dosage Form

-

Strength

EQ 0.5MG BASE

Approval Date

2023-01-25

201962 / 1

Active Ingredient

VARENICLINE TARTRATE

Application Number

201962

Product Number

1

Dosage Form

-

Strength

EQ 0.5MG BASE

Approval Date

2023-01-25

Regulatory Status

RX

2023
25 Jan
RX Application: 201962

Drug Name

VARENICLINE TARTRATE

Product Number

2

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2023-01-25

201962 / 2

Active Ingredient

VARENICLINE TARTRATE

Application Number

201962

Product Number

2

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2023-01-25

Regulatory Status

RX

2009
11 Sep
RX Application: 22110

Drug Name

VIBATIV

Product Number

2

Dosage Form

-

Strength

EQ 750MG BASE/VIAL

Approval Date

2009-09-11

22110 / 2

Active Ingredient

TELAVANCIN HYDROCHLORIDE

Application Number

22110

Product Number

2

Dosage Form

-

Strength

EQ 750MG BASE/VIAL

Approval Date

2009-09-11

Regulatory Status

RX

2023
07 Jul
RX Application: 208228

Drug Name

VILAZODONE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2023-07-07

208228 / 1

Active Ingredient

VILAZODONE HYDROCHLORIDE

Application Number

208228

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2023-07-07

Regulatory Status

RX

2023
07 Jul
RX Application: 208228

Drug Name

VILAZODONE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2023-07-07

208228 / 2

Active Ingredient

VILAZODONE HYDROCHLORIDE

Application Number

208228

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2023-07-07

Regulatory Status

RX

2023
07 Jul
RX Application: 208228

Drug Name

VILAZODONE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

40MG

Approval Date

2023-07-07

208228 / 3

Active Ingredient

VILAZODONE HYDROCHLORIDE

Application Number

208228

Product Number

3

Dosage Form

-

Strength

40MG

Approval Date

2023-07-07

Regulatory Status

RX

2024
10 Jun
RX Application: 218059

Drug Name

ZINC SULFATE

Product Number

1

Dosage Form

-

Strength

EQ 25MG BASE/5ML (EQ 5MG BASE/ML)

Approval Date

2024-06-10

218059 / 1

Active Ingredient

ZINC SULFATE

Application Number

218059

Product Number

1

Dosage Form

-

Strength

EQ 25MG BASE/5ML (EQ 5MG BASE/ML)

Approval Date

2024-06-10

Regulatory Status

RX

2024
28 Oct
RX Application: 218059

Drug Name

ZINC SULFATE

Product Number

2

Dosage Form

-

Strength

EQ 10MG BASE/10ML (EQ 1MG BASE/ML)

Approval Date

2024-10-28

218059 / 2

Active Ingredient

ZINC SULFATE

Application Number

218059

Product Number

2

Dosage Form

-

Strength

EQ 10MG BASE/10ML (EQ 1MG BASE/ML)

Approval Date

2024-10-28

Regulatory Status

RX

2012
02 Mar
RX Application: 77561

Drug Name

ZIPRASIDONE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2012-03-02

77561 / 1

Active Ingredient

ZIPRASIDONE HYDROCHLORIDE

Application Number

77561

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2012-03-02

Regulatory Status

RX

2012
02 Mar
RX Application: 77561

Drug Name

ZIPRASIDONE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2012-03-02

77561 / 2

Active Ingredient

ZIPRASIDONE HYDROCHLORIDE

Application Number

77561

Product Number

2

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2012-03-02

Regulatory Status

RX

2012
02 Mar
RX Application: 77561

Drug Name

ZIPRASIDONE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

EQ 60MG BASE

Approval Date

2012-03-02

77561 / 3

Active Ingredient

ZIPRASIDONE HYDROCHLORIDE

Application Number

77561

Product Number

3

Dosage Form

-

Strength

EQ 60MG BASE

Approval Date

2012-03-02

Regulatory Status

RX

2012
02 Mar
RX Application: 77561

Drug Name

ZIPRASIDONE HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

EQ 80MG BASE

Approval Date

2012-03-02

77561 / 4

Active Ingredient

ZIPRASIDONE HYDROCHLORIDE

Application Number

77561

Product Number

4

Dosage Form

-

Strength

EQ 80MG BASE

Approval Date

2012-03-02

Regulatory Status

RX

Related Databases
  • FDA Inspections
    4 View
  • EDQM CEP
    1 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    558 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
278 total
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ABIRATERONE ACETATE

Application Number

208453

Product Number

1

Active Ingredient

ABIRATERONE ACETATE

Dosage Form

-

Strength

250MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit